FOR IMMEDIATE RELEASE: February 3, 2023 The Therapeutic Goods Administration (TGA) in Australia announced today that they will permit limited use of certain psychedelic-assisted therapies for the treatment …
Summary: “At this moment, when two successful Phase 3 studies of MDMA-assisted therapy for PTSD have brought us closer to potential FDA approval than ever before, MAPS and MAPS PBC must faithfully …
Summary: Technology Networks explores the rapid evolution seen in the world of science today, highlighting the potential benefits of psychedelic-assisted therapy. “The use of marijuana for medical …
Prior Positive Results Confirmed in MAPS-Sponsored, Philanthropy-Funded Phase 3 January 26, 2023 In monumental psychedelic news, on January 5, we confirmed prior positive results in our philanthropy-funded …
Originally appearing here (Archived)
Summary: Founder and Executive Director of MAPS Rick Doblin discusses a new study that supports the psychedelic MDMA as treatment for PTSD on ‘Kennedy.’ Originally appearing here (Archived) …
Summary: Behavioral Health Business publishes an overview of the increasing popularity of psychedelics due largely to the promising psychedelic-assisted research results taking place. Author Laura Lovett …
Originally appearing here (Archived)
Originally appearing here (Archived)
Summary: Andrew Huberman, Ph.D., mentions MAPS and MAPS Founder and Executive Director Rick Doblin, Ph.D., while being interviewed by Tom Segura on the 2 Bears, 1 Cave (YMHstudios) podcast at 39 minutes …
Originally appearing here (Archived)
Summary: In “Healing in a Sick Society,” an episode of the Audible Original The goop Pursuit, Will Siu, M.D., courageously discusses his healing journey. I join Will to discuss the origins …
